Article
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Cell host & microbe - 9 Sept 2020
Dieterle M Eugenia, Haslwanter Denise, Bortz Robert H, Wirchnianski Ariel S, Lasso Gorka, Vergnolle Olivia, Abbasi Shawn A, Fels J Maximilian, Laudermilch Ethan, Florez Catalina, Mengotto Amanda, Kimmel Duncan, Malonis Ryan J, Georgiev George, Quiroz Jose, Barnhill Jason, Pirofski Liise-Anne, Daily Johanna P, Dye John M, Lai Jonathan R, Herbert Andrew S, Chandran Kartik, Jangra Rohit K
Abstract excerpt
There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19. Rapid SARS-CoV-2 countermeasure development is contingent on the availability of robust, scalable, and readily deployable surrogate viral assays to screen antiviral humoral responses, define correlates of immune protection, and down-select candidate antivirals. Here, we generate a highly infectious recombinant vesicular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
